Premier Medical Group of the Hudson Valley is proud to announce that Dr. Evan R. Goldfischer was recently appointed to Chairman of the Advanced Prostate Cancer Expert Panel by the Public Education Council of the Urology Care Foundation , The official foundation of the American Urological Association. Dr. Goldfischer serves as the Medical Director of...Read More
Learn about treatment options for Erectile Dysfunction & Enlarged Prostate. Space is limited so call today to reserve your seat! Spouses and partners are welcome to attend. Light refreshments will be served. Date: Tuesday, October 20, 2015 Time: Registration: 6:15 p.m Seminar: 6:30 p.m. Place: Courtyard Marriott (Crystal Room ) 24 Crystal Run...Read More
Premier Medical Group’s Clinical Research Division is celebrating another clinical trial success with the FDA’s recent announcement on the approval of Flibanserin. Flibanserin is a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder (HSDD). HSDD is the most common form of female sexual dysfunction (FSD) and occurs when there is a persistent lack...Read More
Fourteen years ago, when Bob (not his real name) and his wife decided not to have any more children, Bob had a vasectomy. The couple eventually divorced, Bob recently remarried, and he and his new wife wanted to start a family together. Bob had heard about vasectomy reversal (VR) and contacted Premier Medical Group’s Dr....Read More
With the official opening of Premier Women’s Center for Continence & Sexual Health, women in the Hudson Valley have a dedicated medical practice specifically charged with addressing sensitive health issues in a compassionate and caring environment. The center’s providers offer a full range of treatment options in one comfortable, patient-centric facility. The center actually began...Read More
A team approach to the complexities of advanced PC care. As recently as five years ago, there were very few options available for patients with advanced, metastatic prostate cancer,” says Dr. Evan R. Goldfischer, co-CEO of Premier. Today, however, the situation is much brighter. “A number of new drugs have been approved—with new mechanisms of...Read More
